MedPath

Endometrial Scratch Effect on Pregnancy Rates in Patients Undergoing Egg-donation IVF

Not Applicable
Completed
Conditions
EMBRYO IMPLANTATION
Interventions
Procedure: Endometrial scratch
Registration Number
NCT03108157
Lead Sponsor
Procreatec
Brief Summary

Clinical trial about the effect of endometrial scratch on pregnancy rates in patients undergoing a treatment with in-vitro fertilization with donor eggs, when doing the endometrial biopsy during the cycle prior to the embryo transfer.

Detailed Description

The aim of this clinical trial is to investigate whether an endometrial scratch during the cycle prior to embryo transfer cycle is effective or not in increasing pregnancy rates. Previous studies about this issue have not shown clear conclusions about the effectiveness of this method.

The endometrial scratch is a simple technique that consists in performing a mild injury to all the internal walls of the uterus with a Pipelle Cournier.

To achieve the trial objective, all participating patients are randomly divided into two groups. Once patients decide to participate in the trial, they are assigned to each group according to the randomization list:

Group A: Patients with transfer of fresh embryos after taking an endometrium biopsy during the previous cycle and then following the conventional preparation protocol.

Group B: Patients with transfer of fresh embryos with the conventional preparation protocol.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
352
Inclusion Criteria
  • Female undergoing IVF treatment with donor eggs
Exclusion Criteria
  • Severe male factor ( less tan 2 million spermatozoa per ml )
  • Uterine abnormalities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GROUP A: intervention groupEndometrial scratchPatients will be performed an endometrial scratch with Pipelle Cournier 3 to 4 weeks before the embryo transfer and then they will follow the conventional preparation protocol to receive embryos coming from an egg donation treatment.
Primary Outcome Measures
NameTimeMethod
Positive Pregnancy Test12 to 14 days after embryo transfer

Positive test (hcG\>10 UI/ml)

Clinical Pregnancy5 weeks of pregnancy

Ultrasound confirmation of intrauterine pregnancy

Secondary Outcome Measures
NameTimeMethod
Live BirthPregnancy beyond 24 weeks

Birth after 24 weeks of pregnancy

Trial Locations

Locations (1)

Procreatec

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath